1-4 of 4
François Goldwasser
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I and Pharmacokinetic Study of Irofulven Administered Weekly or Biweekly in Advanced Solid Tumor Patients

Jérôme Alexandre, Eric Raymond, Mahmoud Ould Kaci, Etienne C. Brain, François Lokiec, Carmen Kahatt, Sandrine Faivre, Alejandro Yovine, François Goldwasser, Sheri L. Smith, John R. MacDonald, Jean-Louis Misset, Esteban Cvitkovic
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (10): 3377–3385.
DOI: https://doi.org/10.1158/1078-0432.CCR-03-0349
Published: 24 May 2004
View article
PDF
Journal Articles

Gemcitabine (2′,2′-Difluoro-2′-Deoxycytidine), an Antimetabolite That Poisons Topoisomerase I

Philippe Pourquier, Christopher Gioffre, Glenda Kohlhagen, Yoshimasa Urasaki, François Goldwasser, Lary W. Hertel, Shuyuan Yu, Richard T. Pon, William H. Gmeiner, Yves Pommier
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (8): 2499–2504.
Published: 01 August 2002
View article
PDF
Journal Articles

Ecteinascidin 743 Induces Protein-linked DNA Breaks in Human Colon Carcinoma HCT116 Cells and Is Cytotoxic Independently of Topoisomerase I Expression

Yuji Takebayashi, François Goldwasser, Yoshimasa Urasaki, Glenda Kohlhagen, Yves Pommier
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (1): 185–191.
Published: 01 January 2001
View article
Journal Articles

Cellular Pharmacology of the Combination of the DNA Topoisomerase I Inhibitor SN-38 and the Diaminocyclohexane Platinum Derivative Oxaliplatin

Nadia Zeghari-Squalli, Eric Raymond, Esteban Cvitkovic, François Goldwasser
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (5): 1189–1196.
Published: 01 May 1999
View article
PDF